Congratulations to the wonderfully-talented @adrijanavarro.bsky.social on her #JBC paper out today! We took a dive into the wonderful world of glycobiology, linking it to AKT and oncogene signaling in cancer. Brought to you by Toker Lab productions. @asbmbjournals.bsky.social

🚨 New preprint out! “ALG3 is an AKT substrate that links PI3K signaling to N-glycosylation” 👉 doi.org/10.1101/2025.04.01.646556 This is my big PhD paper—years in the making. So proud to finally share. Huge thanks to Alex Toker, Evan Lien, Laura Ghisolfi, and the Toker lab for all the support. 💛

Ludwig @harvard.edu’s @alextoker.bsky.social discusses his work, what drew him into a life of science and what compels him to contribute to cancer research. youtu.be/IIG5VD8EHB8 #CancerResearch #CancerChat #ImmunoSky

Women are under-represented at senior levels in #academia globally, & across all #science 🧪 disciplines, as shown by these "scissor-shaped curves" ✂️ So how can we ever achieve #gender #equality? We discuss various strategies in this #Cell Commentary #WomeninSTEM www.cell.com/cell/fulltex... 🧵 1/

🎨 In case anyone need… The NIH BioArt Source is an awesome library of *free* professionally drawn illustrations for scientific presentations or figures. Downloadable in HD. Thank you NIH for this invaluable tool 🙏! Check it out 👇 bioart.niaid.nih.gov

Published a few weeks ago in Cancer Research, we show benefit of targeting HMCR with pitavastatin in combo with AKT inhibitors in TNBC. Many amazing people contributed, led by the magnificently talented @alissandra-hillis.bsky.social! Looking to initiate new clinical trials based on this combo. 🧪

It was such a pleasure to organize for Harry the Healer to come to our lab yesterday! Not only did he have the cutest badge, but his calming and healing nature were very helpful in rejuvenating spirits for all our hard working scientists!